Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancerNicole F. Bonan, Kathleen DeCicco-Skinner|Oncogenesis|2019Cited by 33
Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment ResponseMaria Ochiai, Kathleen DeCicco-Skinner|Cancers|2023Cited by 8
Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytesMary Kelley, Kathleen DeCicco-Skinner|PLoS ONE|2022Cited by 1
Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2−/− MiceLaura R. Purkey, Kathleen DeCicco-Skinner|Cancers|2025Cited by 0